178 related articles for article (PubMed ID: 6215331)
1. Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR.
Hirschberg H; Braathen LR; Thorsby E
Immunol Rev; 1982; 66():57-77. PubMed ID: 6215331
[No Abstract] [Full Text] [Related]
2. The functional study of DR-positive human epidermal Langerhans cells in mixed cell cultures with allogeneic lymphocytes.
Pollack MS; Goldenhersh M; Chin-Louie J; Safai B
Clin Immunol Immunopathol; 1982 Jul; 24(1):15-25. PubMed ID: 6213344
[No Abstract] [Full Text] [Related]
3. Antigen-presenting properties of human vascular endothelial cells.
Hirschberg H; Bergh OJ; Thorsby E
J Exp Med; 1980 Aug; 152(2 Pt 2):249s-255s. PubMed ID: 6157767
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies against HLA-DR antigens acting on stimulator cells prevent OKT8+ T lymphocytes from acquiring sensitivity to interleukin 2 and expressing suppressor function.
Palacios R; Guy K; Van Heyningen V
Eur J Immunol; 1983 Jan; 13(1):64-72. PubMed ID: 6219882
[No Abstract] [Full Text] [Related]
5. Endothelial cell presentation of antigen to human T cells.
Burger DR; Ford D; Vetto RM; Hamblin A; Goldstein A; Hubbard M; Dumonde DC
Hum Immunol; 1981 Nov; 3(3):209-30. PubMed ID: 6975768
[TBL] [Abstract][Full Text] [Related]
6. HLA-D region molecules restrict proliferative T cell responses to antigen.
Thorsby E; Berle E; Nousiainen H
Immunol Rev; 1982; 66():39-56. PubMed ID: 6182089
[No Abstract] [Full Text] [Related]
7. Antigen-presenting properties of human vascular endothelial cells: inhibition by anti-HLA-DR antisera.
Hirschberg H; Hirschberg T; Jaffe E; Thornsby E
Scand J Immunol; 1981 Nov; 14(5):545-53. PubMed ID: 6977827
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.
Masuyama J; Minato N; Kano S
J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562
[TBL] [Abstract][Full Text] [Related]
9. The antigen-presenting function of human Langerhans cells.
Braathen LR; Bjercke S; Thorsby E
Immunobiology; 1984 Dec; 168(3-5):301-12. PubMed ID: 6241602
[No Abstract] [Full Text] [Related]
10. Involvement of class II HLA molecules in T cell activation by antigen. Implications for the autologous mixed lymphocyte reaction.
Thorsby E; Berle E; Scott H; Braathen LR
Behring Inst Mitt; 1983 May; (72):129-34. PubMed ID: 6100471
[TBL] [Abstract][Full Text] [Related]
11. Immunologic function of endothelial cells: guinea pig aortic endothelial cells support mitogen-induced T lymphocyte activation, but do not function as antigen-presenting cells.
Roska AK; Johnson AR; Lipsky PE
J Immunol; 1984 Jan; 132(1):136-45. PubMed ID: 6197441
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation.
Meunier L; Bohjanen K; Voorhees JJ; Cooper KD
J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614
[TBL] [Abstract][Full Text] [Related]
13. Loss of allogeneic T-cell activating ability and Langerhans cell markers in human epidermal cell cultures.
Demidem A; Faure M; Dezutter-Dambuyant C; Thivolet J
Clin Immunol Immunopathol; 1986 Mar; 38(3):319-26. PubMed ID: 2935342
[TBL] [Abstract][Full Text] [Related]
14. The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions.
Sontheimer RD
J Invest Dermatol; 1985 Jul; 85(1 Suppl):21s-26s. PubMed ID: 3159806
[TBL] [Abstract][Full Text] [Related]
15. Human suppressor cell induction in vitro: preferential activation by class I MHC antigen.
Goeken NE
J Immunol; 1984 May; 132(5):2291-9. PubMed ID: 6232315
[TBL] [Abstract][Full Text] [Related]
16. Human epidermal cell-induced generation of alloreactive cytotoxic T-lymphocyte responses against epidermal cells. Requirement for DR-positive Langerhans cells.
Faure M; Dezutter-Dambuyant C; Schmitt D; Gaucherand M; Thivolet J
Scand J Immunol; 1985 May; 21(5):441-6. PubMed ID: 3159078
[TBL] [Abstract][Full Text] [Related]
17. Langerhans cell induced cytotoxic T-cell responses against normal human epidermal cell targets: in vitro studies.
Faure M; Dezutter-Dambuyant C; Schmitt D; Gaucherand M; Thivolet J
Br J Dermatol; 1985 Jul; 113 Suppl 28():114-7. PubMed ID: 3160381
[TBL] [Abstract][Full Text] [Related]
18. The genetic control of human Ia alloantigens: a three-loci model derived from the immunochemical analysis of 'supertypic' specificities.
Tanigaki N; Tosi R
Immunol Rev; 1982; 66():5-37. PubMed ID: 6182090
[No Abstract] [Full Text] [Related]
19. In vitro studies of epidermal antigen-presenting cells. The mixed skin lymphocyte reaction: an in vitro model for the generation of alloreactive cytotoxic T cells by human epidermal cells.
Faure M; Schmitt D; Dezutter-Dambuyant C; Frappaz A; Gaucherand M; Thivolet J
Br J Dermatol; 1984 Jul; 111 Suppl 27():11-7. PubMed ID: 6234919
[TBL] [Abstract][Full Text] [Related]
20. Subcultured human endothelial cells can function independently as fully competent antigen-presenting cells.
Wagner CR; Vetto RM; Burger DR
Hum Immunol; 1985 May; 13(1):33-47. PubMed ID: 3872868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
